Sean Sheridan, in an article published in Law360, provides an overview of recent high-profile court cases that have addressed the issue of patentable subject matter. The article also describes how these decisions are changing patent examination at the U.S. Patent and Trademark Office and discusses how the changing scope of patent-eligible subject matter may impact intellectual property valuations and transactions in the life sciences field. To read the article, click the link below.
IP Literature Watch: August 2025
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...